The generation of nfkb2 p52:: mechanism and efficiency

被引:95
作者
Heusch, M
Lin, L
Geleziunas, R
Greene, WC
机构
[1] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94141 USA
[3] Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94141 USA
[4] Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94141 USA
基金
英国医学研究理事会;
关键词
nfkb2; cotranslational processing; p52; p100; proteasome;
D O I
10.1038/sj.onc.1203022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
nfkb2 encodes two members of the NF-kappa B/Rel family of proteins: p52 and p100. The p100 polypeptide has been proposed to serve as a precursor of p52, which corresponds to the N-terminal half of p100. While p52 functions as a Rel transcription factor,the larger p100 protein acts as a cytoplasmic inhibitor of select NF-kappa B/Rel transcription factor complexes. Because of their distinct functions, we have studied the biochemical basis for the production of these two nfkb2-derived gene products. Like the p50 product of the nfkb1 gene, p52 is principally generated in a cotranslational manner involving proteolytic processing by the proteasome. The generation of p52 is dependent on a glycine-rich region (GRR) located upstream of the p52 C-terminus, and repositioning of this GRR alters the location of proteasome processing. In most cells, small amounts of p52 are produced relative to the levels of p100, unlike the usually balanced production of nfkb1-derived p50 and p105. Using p100/p105 chimeras containing different segments of the nfkb1 and nfkb2 genes, we have found that diminished p52 processing is a property conferred by peptide sequences located downstream of the GRR, flanking the site of p52 processing.
引用
收藏
页码:6201 / 6208
页数:8
相关论文
共 31 条
[1]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[2]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[3]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[4]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[5]   The proteasome:: Paradigm of a self-compartmentalizing protease [J].
Baumeister, W ;
Walz, J ;
Zühl, F ;
Seemuller, E .
CELL, 1998, 92 (03) :367-380
[6]   HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I TAX ASSOCIATES WITH AND IS NEGATIVELY REGULATED BY THE NF-KAPPA-B2 P100 GENE-PRODUCT - IMPLICATIONS FOR VIRAL LATENCY [J].
BERAUD, C ;
SUN, SC ;
GANCHI, P ;
BALLARD, DW ;
GREENE, WC .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (02) :1374-1382
[7]  
Betts JC, 1996, MOL CELL BIOL, V16, P6363
[8]   THE ONCOPROTEIN BCL-3 DIRECTLY TRANSACTIVATES THROUGH KAPPA-B MOTIFS VIA ASSOCIATION WITH DNA-BINDING P50B HOMODIMERS [J].
BOURS, V ;
FRANZOSO, G ;
AZARENKO, V ;
PARK, S ;
KANNO, T ;
BROWN, K ;
SIEBENLIST, U .
CELL, 1993, 72 (05) :729-739
[9]   A NOVEL MITOGEN-INDUCIBLE GENE-PRODUCT RELATED TO P50/P105-NF-KAPPA-B PARTICIPATES IN TRANSACTIVATION THROUGH A KAPPA-B SITE [J].
BOURS, V ;
BURD, PR ;
BROWN, K ;
VILLALOBOS, J ;
PARK, S ;
RYSECK, RP ;
BRAVO, R ;
KELLY, K ;
SIEBENLIST, U .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (02) :685-695
[10]   CENTRAL OF I-KAPPA-B-ALPHA PROTEOLYSIS BY SITE-SPECIFIC, SIGNAL-INDUCED PHOSPHORYLATION [J].
BROWN, K ;
GERSTBERGER, S ;
CARLSON, L ;
FRANZOSO, G ;
SIEBENLIST, U .
SCIENCE, 1995, 267 (5203) :1485-1488